XML 34 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating Activities    
Net income available to common shareholders $ 29,000 $ 21,619
Adjustments to reconcile net income to net cash provided by operating activities:    
(Accretion) and amortization, net (422) 455
Provision for (recovery of) credit losses 7,972 (849)
Depreciation of premises and equipment 1,325 1,209
Deferred income tax expense (824) 1,922
Net periodic employee benefit cost 181 193
Unrealized and realized investment securities losses (gains), net 2,339 (163)
Stock-compensation expense 1,009 803
Excess tax benefit from stock-compensation expense (121) (77)
Increase in value of bank-owned life insurance (1,676) (1,016)
Loans originated for sale (2,327) (4,325)
Proceeds from the sale of loans originated for sale 2,229 5,939
Gain on sale of loans (77) (165)
Change in accrued interest receivable (1,001) (1,233)
Change in other assets (5,926) (4,193)
Change in other liabilities 8,937 (57)
Net Cash Provided by Operating Activities 40,618 20,062
Investing Activities    
Net decrease in loans 6,442 26,920
Purchases (94,151) (61,432)
Proceeds from sales 26,090 25,062
Proceeds from maturities and calls 20,644 15,432
Securities Held-to-maturity: Proceeds from maturities and calls 0 5,484
Other investments: Purchases (1,357) (9,006)
Other investments: Proceeds from sales 624 11,715
Purchases of premises and equipment (3,329) (1,576)
Disposals of premises and equipment 119 30
Proceeds from life insurance 1,412 304
Sale of Ashland office, net 440 0
Net Cash (Used in) Provided by Investing Activities (43,066) 12,933
Financing Activities    
Net increase in non-interest-bearing deposits 52,414 4,514
Net (decrease) increase in interest-bearing deposits (76,100) 63,190
Net increase (decrease) in short-term borrowings 22,892 (67,228)
Repayment of long-term debt 4,124 0
Purchases of treasury stock (12,971) (4,089)
Proceeds from exercise of stock options 122 252
Dividends paid (9,293) (8,775)
Net Cash Used in Financing Activities (27,060) (12,136)
(Decrease) Increase in Cash and Cash Equivalents (29,508) 20,859
Cash and cash equivalents at beginning of period 140,144 122,991
Cash and Cash Equivalents at End of Period $ 110,636 $ 143,850